Thermo Fisher Scientific Inc (TMO) concluded trading on Wednesday at a closing price of $466.71, with 8.93 million shares of worth about $4.17 billion changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -18.56% during that period and on July 23, 2025 the price saw a gain of about 9.14%. Currently the company’s common shares owned by public are about 377.49M shares, out of which, 376.86M shares are available for trading.
Stock saw a price change of 12.11% in past 5 days and over the past one month there was a price change of 16.62%. Year-to-date (YTD), TMO shares are showing a performance of -12.66% which decreased to -10.29% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $385.46 but also hit the highest price of $627.88 during that period. The average intraday trading volume for Thermo Fisher Scientific Inc shares is 2.75 million. The stock is currently trading 10.54% above its 20-day simple moving average (SMA20), while that difference is up 13.24% for SMA50 and it goes to -5.89% lower than SMA200.
Thermo Fisher Scientific Inc (NYSE: TMO) currently have 377.49M outstanding shares and institutions hold larger chunk of about 91.31% of that.
The stock has a current market capitalization of $176.18B and its 3Y-monthly beta is at 0.74. PE ratio of stock for trailing 12 months is 27.01, while it has posted earnings per share of $17.28 in the same period. Its PEG reads 3.65 and has Quick Ratio of 1.50 while making debt-to-equity ratio of 0.70. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TMO, volatility over the week remained 4.18% while standing at 3.22% over the month.
Stock’s fiscal year EPS is expected to rise by 2.62% while it is estimated to increase by 9.05% in next year. EPS is likely to shrink at an annualized rate of 7.41% for next 5-years, compared to annual growth of 12.52% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Scotiabank on July 11, 2025 offering a Sector outperform rating for the stock and assigned a target price of $590 to it. Coverage by UBS stated Thermo Fisher Scientific Inc (TMO) stock as a Neutral in their note to investors on July 09, 2025, suggesting a price target of $460 for the stock. Stock get a Buy rating from Redburn Atlantic on October 14, 2024.
